Welcome!
Featured Video
Company Overview
Grifols is a global healthcare company that since its founding in Barcelona in 1909 has enhanced the health and well-being of people around the world. Our four divisions – Bioscience, Diagnostic, Hospital, and Bio Supplies – develop, produce, and market innovative solutions and services in more than 100 countries.
As a recognized leader in transfusion medicine, the Diagnostic division shares the commitment to increase transfusion safety from donation to transfusion. The division offers a comprehensive portfolio, while helping to manage and simplify laboratory operations. Additionally, the division offers a portfolio of specialized clinical diagnostics focused on select therapeutic areas.
Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety, and ethical leadership in the industry.

History Driven By Innovation
Key milestones throughout our diagnostic history
Learn more by rolling over the image.
A Global Leader In Transfusion Medicine
Supporting Decision Making Across The Healthcare Continuum
Screening
Blood and plasma infectious disease screening
Donor and patient blood compatibility typing
Blood bags, instruments, and supplies for blood collection and separation
Antigen manufacturing
Diagnosis
Infectious disease
Autoimmunity
Neurodegenerative
Prognosis
Blood clotting and thrombosis risk
Treatment/
Monitoring
Transfusion component process tracking and traceability
Autoimmunity testing
Biological drug monitoring
Treatment monitoring for blood thinner